JPS61158967A - ５−シアノピリジン−２−ジアゾヒドロキシドの塩基性塩およびその製法および使用法 - Google Patents

５−シアノピリジン−２−ジアゾヒドロキシドの塩基性塩およびその製法および使用法

Info

Publication number
JPS61158967A
JPS61158967A JP60253621A JP25362185A JPS61158967A JP S61158967 A JPS61158967 A JP S61158967A JP 60253621 A JP60253621 A JP 60253621A JP 25362185 A JP25362185 A JP 25362185A JP S61158967 A JPS61158967 A JP S61158967A
Authority
JP
Japan
Prior art keywords
salt
cyanopyridine
diazohydroxide
compounds
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60253621A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0146511B2 (enExample
Inventor
デイヴイツド　シー　ベイカー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alabama
University of Alabama at Birmingham
Original Assignee
University of Alabama
University of Alabama at Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alabama, University of Alabama at Birmingham filed Critical University of Alabama
Publication of JPS61158967A publication Critical patent/JPS61158967A/ja
Publication of JPH0146511B2 publication Critical patent/JPH0146511B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP60253621A 1984-11-13 1985-11-12 ５−シアノピリジン−２−ジアゾヒドロキシドの塩基性塩およびその製法および使用法 Granted JPS61158967A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/670,203 US4636564A (en) 1984-11-13 1984-11-13 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use
US670203 1984-11-13

Publications (2)

Publication Number Publication Date
JPS61158967A true JPS61158967A (ja) 1986-07-18
JPH0146511B2 JPH0146511B2 (enExample) 1989-10-09

Family

ID=24689433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60253621A Granted JPS61158967A (ja) 1984-11-13 1985-11-12 ５−シアノピリジン−２−ジアゾヒドロキシドの塩基性塩およびその製法および使用法

Country Status (10)

Country Link
US (1) US4636564A (enExample)
EP (1) EP0181636B1 (enExample)
JP (1) JPS61158967A (enExample)
AT (1) ATE50566T1 (enExample)
AU (1) AU576914B2 (enExample)
CA (1) CA1255654A (enExample)
DE (1) DE3576154D1 (enExample)
DK (1) DK159847C (enExample)
ES (1) ES8700238A1 (enExample)
ZA (1) ZA858315B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816468A (en) * 1984-11-13 1989-03-28 The University Of Alabama 5-cyanopyridine-2-diazohydroxide, basic salts and use
DE4301109A1 (de) * 1993-01-18 1994-07-21 Bayer Ag Verfahren zur Herstellung von 6-Amino-nicotinsäurenitrilen
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica
CN107602456B (zh) * 2017-10-19 2021-04-06 北京印刷学院 偶氮吡啶盐化合物及制备方法

Also Published As

Publication number Publication date
ATE50566T1 (de) 1990-03-15
AU576914B2 (en) 1988-09-08
DK514285A (da) 1986-05-14
CA1255654A (en) 1989-06-13
EP0181636A3 (en) 1987-04-01
EP0181636B1 (en) 1990-02-28
JPH0146511B2 (enExample) 1989-10-09
DE3576154D1 (de) 1990-04-05
ES8700238A1 (es) 1986-10-01
EP0181636A2 (en) 1986-05-21
ZA858315B (en) 1986-10-29
DK159847B (da) 1990-12-17
DK514285D0 (da) 1985-11-07
AU4983585A (en) 1986-05-22
DK159847C (da) 1991-05-13
US4636564A (en) 1987-01-13
ES548791A0 (es) 1986-10-01

Similar Documents

Publication Publication Date Title
AU599034B2 (en) Furosemide salts
AU592559B2 (en) 5-Pyrimidinecarboxamides and treatment of leukemia and tumors therewith
US3709991A (en) Hypolipidemic method
US3933827A (en) 9-Acyloxy-5,11-dimethyl-6H-pyrido[4,3-B]carbazoles
US4103009A (en) Benzoguanamine derivatives
US4636564A (en) 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use
US4098892A (en) Nicotinamido-s-triazines
JPS6147808B2 (enExample)
JPS61158970A (ja) ピラジンジアゾヒドロキシド化合物
US4053621A (en) 1-[2-(βNaphthyloxy)ethyl]-3-methylpyrazolone-(5) and antithrombotic and antithrombolytic compositions and methods utilizing them
US3157573A (en) Antihypertensive 3, 4-dihydro-2(1h)-isoquinolinecarboxamidine
US4816468A (en) 5-cyanopyridine-2-diazohydroxide, basic salts and use
EP0335408A2 (en) Substituted benzene derivatives, processes for their production and antitumour compositions containing them
US4201775A (en) Bis[triethylphosphine)aurio]sulfonium sugars
US4224327A (en) 4-Pyrimidyl sulfides for the treatment of gastric ulcers
US2726983A (en) Isonicotinic acid hydrazones and antituberculous compositions thereof
US4845101A (en) Pyrazine diazohydroxide compositions and method of use as cytostatic agent
US3042581A (en) New salts of isonicotinic acid hydrazone compounds and a process of making same
US7019156B2 (en) Tumor inhibiting gallium compounds
US3738990A (en) Nicotinic acid derivatives
US3317391A (en) Composition for treatment of angina pectoris and process for preparing same
US3907776A (en) Cardiac glycosides
US4007198A (en) Substituted 1,2,4-triazole carboxamide
US4098887A (en) Pharmaceutical compositions and methods of producing antiarthritic activity with bis(pyridine)gold(1+) salts
US3069318A (en) 2-lower alkyl-4, 5-dihydro-3-pyridazinone-6-carboxamides and antitussive compositions